Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS No: 49579 40 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111675662B enables cost-effective manufacturing of high-purity quinazolinone intermediates through iron-catalyzed cyclization with reliable supply chain integration.
Novel iron-catalyzed synthesis enables high-purity quinazolinone intermediates with simplified purification and scalable manufacturing for pharmaceutical supply chains.
Iron-catalyzed synthesis enables high-purity quinazolinone intermediates with scalable production and reduced lead time for pharmaceutical applications.